ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 143 filers reported holding ASCENDIS PHARMA A/S in Q1 2019. The put-call ratio across all filers is 0.49 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $442,000 | -4.7% | 4,592 | +13.9% | 0.01% | -10.0% |
| Q2 2019 | $464,000 | +4.3% | 4,032 | +6.7% | 0.01% | 0.0% |
| Q1 2019 | $445,000 | +34.8% | 3,780 | -28.2% | 0.01% | +25.0% |
| Q4 2018 | $330,000 | -49.0% | 5,264 | -42.3% | 0.01% | -38.5% |
| Q3 2018 | $647,000 | +9.8% | 9,128 | +3.2% | 0.01% | 0.0% |
| Q2 2018 | $589,000 | +14.1% | 8,848 | +12.1% | 0.01% | +8.3% |
| Q1 2018 | $516,000 | – | 7,896 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
| RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
| Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
| Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
| Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
| Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
| Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
| Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
| Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
| Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |